Intravesical hyaluronic acid (HA) and chondroitin sulphate (CS) for treatment of signs and symptoms of patients with late radiation tissue cystitis (LRTC): an investigative pilot study
Not Applicable
Completed
- Conditions
- ate radiation tissue cystitis with or without haematuriaUrological and Genital DiseasesIrradiation cystitis
- Registration Number
- ISRCTN37534393
- Lead Sponsor
- Institut Biochimique SA (IBSA) (Italy)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Eligible patients with symptomatic LRTC after receiving primary or adjuvant radiotherapy for pelvic neoplasms
Exclusion Criteria
1. Patients (male and female, age range: 40-80 years) undergoing chemotherapy
2. Those with a life expectancy of less than 24 months
3. Those with radiological confirmed metastasis
4. Patients receiving radiotherapy for bladder cancer
5. Patients with documented urethral strictures
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The tolerability, safety and efficacy of the treatment at reducing the symptoms and signs of LRTC at 3 and 12 months
- Secondary Outcome Measures
Name Time Method Quality of Life (QoL), measured at 3 and 12 months